Cargando…
Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 molecule
Programmed cell death 1 (PD-1) is an immune checkpoint molecule regulating T-cell function. Preventing PD-1 binding to its ligand PD-L1 has emerged as an important tool in immunotherapy. Here, we describe a unique human catalytic antibody light chain, H34, which mediates enzymatic degradation of hum...
Autores principales: | Hifumi, Emi, Taguchi, Hiroaki, Nonaka, Tamami, Harada, Takunori, Uda, Taizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341958/ https://www.ncbi.nlm.nih.gov/pubmed/34458785 http://dx.doi.org/10.1039/d0cb00155d |
Ejemplares similares
-
A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain
por: Hifumi, Emi, et al.
Publicado: (2022) -
Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving Antigens
por: Nonaka, Tamami, et al.
Publicado: (2022) -
New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β‐amyloid molecule along with the peptidase activity
por: Hifumi, Emi, et al.
Publicado: (2019) -
Direct conversion of a general antibody to its catalytic antibody and corresponding applications —Importance and role of Pro95 in CDR-3—
por: HIFUMI, Emi, et al.
Publicado: (2023) -
A new algorithm to convert a normal antibody into the corresponding catalytic antibody
por: Hifumi, Emi, et al.
Publicado: (2020)